Insider · CIK 0002061504
Douglas P Golwas
Files at MDLN (Medline Inc.). First filing Jun 17, 2026, latest Jun 17, 2026.
Douglas P Golwas files SEC Form 4 as officer and 10% owner at MDLN (Medline Inc.). Since Jun 17, 2026, Douglas P Golwas has reported 0 open-market buys worth $0 and 1 open-market sell worth $3.7M, the latest filed on Jun 17, 2026.
A track record needs three past buys with six months of prices behind them; Douglas P Golwas has 0, so none is measured yet.
The newest scored trade: sold $3.7M of MDLN on Jun 16, 2026, filed Jun 17, 2026, scored 25 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 1 sell worth $3.7M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
MDLN: Medline Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 25Weak | Medline Inc. | $3.7M 100,000 shares | -81% | +12% from low-26% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jun 16, 2026 | MDLN Medline Inc. | 100,000 0.01% of outstanding | $3.6M | Jun 16, 2026 | none |
Transactions
Every row this insider has filed, 14 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | MDLN Medline Inc. | FTax withholding Class A Common Stock10b5-1 | -1,889 | $36.61 | $69k | 23,899 | Jun 17, 2026 |
| Jun 16, 2026 | MDLN Medline Inc. | MOption exercise Class A Common Stock10b5-1 | +100,000 | - | - | 123,899 | Jun 17, 2026 |
| Jun 16, 2026 | MDLN Medline Inc. | SOpen-market sale Class A Common Stock10b5-1 | -61,966 | $36.60 | $2.3M | 61,933 | Jun 17, 2026 |
| Jun 16, 2026 | MDLN Medline Inc. | SOpen-market sale Class A Common Stock10b5-1 | -38,034 | $37.05 | $1.4M | 23,899 | Jun 17, 2026 |
| Jun 16, 2026 | MDLN Medline Inc. | DDisposition to issuer Class B Common Stock10b5-1 | -100,000 | - | - | 365,864 | Jun 17, 2026 |
| Jun 16, 2026 | MDLN Medline Inc. | MOption exercise Common Units of Medline Holdings, LPderivativeindirect: See Footnote10b5-1 | -100,000 | $0.00 | $0 | 365,864 | Jun 17, 2026 |
| Dec 16, 2025 | MDLN Medline Inc. | AGrant or award Class B Common Stock | +465,864 | - | - | 465,864 | Mar 6, 2026 |
| Mar 5, 2026 | MDLN Medline Inc. | AGrant or award Class A Common Stock | +25,788 | $0.00 | $0 | 25,788 | Mar 6, 2026 |
| Dec 16, 2025 | MDLN Medline Inc. | AGrant or award Common Units of Medline Holdings, LPderivativeindirect: See Footnote | +465,864 | - | - | 465,864 | Mar 6, 2026 |
| Dec 16, 2025 | MDLN Medline Inc. | AGrant or award Incentive Units of Medline Holdings, LPderivativeindirect: See Footnote | +948,597 | - | - | 948,597 | Mar 6, 2026 |
| Dec 16, 2025 | MDLN Medline Inc. | AGrant or award Incentive Units of Medline Holdings, LPderivativeindirect: See Footnote | +463,211 | - | - | 463,211 | Mar 6, 2026 |
| Dec 16, 2025 | MDLN Medline Inc. | AGrant or award Incentive Units of Medline Holdings, LPderivativeindirect: See Footnote | +212,755 | - | - | 212,755 | Mar 6, 2026 |
| Dec 16, 2025 | MDLN Medline Inc. | AGrant or award Incentive Units of Medline Holdings, LPderivativeindirect: See Footnote | +157,800 | - | - | 157,800 | Mar 6, 2026 |
| Dec 16, 2025 | MDLN Medline Inc. | AGrant or award Incentive Units of Medline Holdings, LPderivativeindirect: See Footnote | +149,005 | - | - | 149,005 | Mar 6, 2026 |
Questions about Douglas P Golwas
Answered from the filings on this page, as of the latest one.
Is Douglas P Golwas buying or selling?
In the last 12 months Douglas P Golwas reported 0 open-market buys worth $0 and 1 open-market sell worth $3.7M on SEC Form 4; the latest was sold $3.7M of MDLN on Jun 16, 2026. Grants, option exercises and tax withholding are not counted.
How did Douglas P Golwas's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Douglas P Golwas has 0.
Where does Douglas P Golwas file Form 4?
Douglas P Golwas has filed Form 4 at MDLN (Medline Inc.) as Chief Commercial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.